Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Induced abortions in women with rheumatoid arthritis receiving methotrexate.

Vinet É, Kuriya B, Pineau CA, Clarke AE, Bernatsky S.

Arthritis Care Res (Hoboken). 2013 Aug;65(8):1365-9. doi: 10.1002/acr.22000.

2.
4.

Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.

Solomon DH, Avorn J, Katz JN, Weinblatt ME, Setoguchi S, Levin R, Schneeweiss S.

Arthritis Rheum. 2006 Dec;54(12):3790-8.

5.
6.

Oral events related to low-dose methotrexate in rheumatoid arthritis patients.

Pedrazas CH, Azevedo MN, Torres SR.

Braz Oral Res. 2010 Jul-Sep;24(3):368-73.

7.

Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis.

Schneeweiss S, Setoguchi S, Weinblatt ME, Katz JN, Avorn J, Sax PE, Levin R, Solomon DH.

Arthritis Rheum. 2007 Jun;56(6):1754-64.

8.

Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumour necrosis factor-alpha antibody compared with methotrexate in long-standing rheumatoid arthritis.

Barrera P, van der Maas A, van Ede AE, Kiemeney BA, Laan RF, van de Putte LB, van Riel PL.

Rheumatology (Oxford). 2002 Apr;41(4):430-9.

9.

Patterns of medication use during pregnancy in rheumatoid arthritis.

Kuriya B, Hernández-Díaz S, Liu J, Bermas BL, Daniel G, Solomon DH.

Arthritis Care Res (Hoboken). 2011 May;63(5):721-8. doi: 10.1002/acr.20422.

10.

Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication.

Hoshida Y, Xu JX, Fujita S, Nakamichi I, Ikeda J, Tomita Y, Nakatsuka S, Tamaru J, Iizuka A, Takeuchi T, Aozasa K.

J Rheumatol. 2007 Feb;34(2):322-31. Epub 2006 Nov 15.

PMID:
17117491
11.
13.

Methotrexate chronotherapy is effective against rheumatoid arthritis.

To H, Yoshimatsu H, Tomonari M, Ida H, Tsurumoto T, Tsuji Y, Sonemoto E, Shimasaki N, Koyanagi S, Sasaki H, Ieiri I, Higuchi S, Kawakami A, Ueki Y, Eguchi K.

Chronobiol Int. 2011 Apr;28(3):267-74. doi: 10.3109/07420528.2011.553017.

PMID:
21452922
14.

No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort study.

Weber-Schoendorfer C, Hoeltzenbein M, Wacker E, Meister R, Schaefer C.

Rheumatology (Oxford). 2014 Apr;53(4):757-63. doi: 10.1093/rheumatology/ket390. Epub 2013 Dec 24.

15.

Abortion surveillance--United States, 2009.

Pazol K, Creanga AA, Zane SB, Burley KD, Jamieson DJ; Centers for Disease Control and Prevention (CDC).

MMWR Surveill Summ. 2012 Nov 23;61(8):1-44.

16.
17.

Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.

Stamp LK, O'Donnell JL, Chapman PT, Zhang M, Frampton C, James J, Barclay ML.

Arthritis Rheum. 2009 Aug;60(8):2248-56. doi: 10.1002/art.24653.

18.

Induced abortions and risk of ectopic pregnancy.

Parazzini F, Ferraroni M, Tozzi L, Ricci E, Mezzopane R, La Vecchia C.

Hum Reprod. 1995 Jul;10(7):1841-4.

PMID:
8582994
19.

Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register.

Verstappen SM, King Y, Watson KD, Symmons DP, Hyrich KL; BSRBR Control Centre Consortium, BSR Biologics Register.

Ann Rheum Dis. 2011 May;70(5):823-6. doi: 10.1136/ard.2010.140822. Epub 2011 Feb 28.

20.

Methotrexate and misoprostol for early abortion: a multicenter trial. I. Safety and efficacy.

Creinin MD, Vittinghoff E, Keder L, Darney PD, Tiller G.

Contraception. 1996 Jun;53(6):321-7.

PMID:
8773418
Items per page

Supplemental Content

Write to the Help Desk